Getinge Holding USA, Inc.

Wayne, NJ ManufacturingNAICS 339110

Self-funded health planPlan year 2025Renews January
2,968Participants+3% vs. prior year
$7.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#20 of 76Manufacturing in NJBy participants

Overview

Getinge Holding USA, Inc. sponsors a self-funded health plan that covered 2,968 participants in plan year 2025, up 3% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,968 · prior year 2,897
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Getinge Holding USA, Inc. Health and Welfare Plan, plan 501 (2,968 participants)
Stop-loss carrier
Sun Life Assurance Company of Canada
Broker compensation
$483K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Sun Life Assurance Company of CanadaStop-loss2,407$6.4M$380K
Cigna Health and Life Insurance Company and AffiliatesDental2,482$2.9M—
Life Insurance Company of North AmericaAccident, Life, Long-term disability, Hospital Indemnity, Critical Illness3,275$2.6M$93K
EyemedVision2,326$266K—
Health Advocate Solutions, Inc.EAP, Advocacy2,940$117K—
First Reliance Standard Life Insurance CompanyDisability Benefit Law, Weekly Income210$48K$844
Metropolitan General Insurance CompanyLegal200$44K$8K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$7.0M/ year

Estimated prescription spend: 2,968 participants × $2,371 national average per member. Usually higher once dependents are counted.

$183K–$451K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$53K–$134K
Lower-cost therapeutic alternatives$78K–$163K
Generic pricing vs. actual cost$34K–$101K
PBM contract terms$18K–$53K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Getinge Holding USA, Inc.
Sponsor EIN
36-3750713
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 36-3750713 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Getinge Holding USA, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Getinge Holding USA, Inc..

Request a correction · Methodology